Name | CT-721 |
---|
Description | CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM for wild-type Bcr-Abl kinase, and possesses anti-chronic myeloid leukemia (CML) activities[1]. |
---|---|
Related Catalog | |
Target |
IC50: 21.3 nM (wild-type Bcr-Abl kinase)[1] |
References |
Molecular Formula | C30H29ClN6O |
---|---|
Molecular Weight | 525.04 |
Hazard Codes | Xi |
---|